Sanofi Launched Advanced Treatment for Pompe Disease
Benjamin LAMBERG, CCIFT's Chairman, established Team France spirit at the opening.
Sanofi hosted a launch event of advanced treatment for Pompe disease on April 22, 2023. We welcomed 95 healthcare professionals for Pompe disease care joined on-site or virtually. Patients with Pompe disease, their caregivers and the CCI French Taiwan representative were invited to the opening session to celebrate the launch.
Olivier FILICIC, Head of Rare Disease of Sanofi Taiwan, shared that Pompe disease is a rare, progressive, and life-threatening muscle disorder. He was invited to the International Pompe Day event hosted by Taiwan Pompe Association and was deeply touched and encouraged by patient story.
In the opening session, patients and caregiver shared their journey with Pompe disease. They felt depressed when getting diagnosed with Pompe disease, but still faced it with courage, treating and rehabilitating actively. They appreciated HCPs' efforts and development of the advanced treatment, providing better care to them, expecting the advanced treatment benefits more patients.
Sanofi has cultivated in Taiwan for nearly 40 years and committed to the pursuit of better care for rare. We’ve supported about 70 hospitals to strengthen their newborn and high-risk screening. Also, we are dedicated to increasing patient access to innovative treatment and providing integrated support along the patient journey as well. Sanofi' s mission remains clear: we strive to enable fulfilling futures for extraordinary people, no matter how rare their condition.
Benjamin LAMBERG, the chairman of CCIFT, was proud to present that France as an important strategic partner of Taiwan, and the cooperation between our two countries is very strong and will get stronger. CCIFT have more than 200 members, include luxury, aviation, industry, electronics and semiconductors, energy etc. Sanofi is one of its industrial gems of France. A global market leader – but more importantly an innovative leader providing care for rare disease, hemophilia, diabetes, and cardiovascular diseases, and provide vaccines for prevention.
Read more about Sanofi here: https://www.sanofi.com.tw/zh/press-release
